Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 7210783, 12 pages
https://doi.org/10.1155/2018/7210783
Research Article

α-Tocopherol Ameliorates Redox Equilibrium and Reduces Inflammatory Response Caused by Chronic Variable Stress

1Department of Toxicology, Medical University of Lublin, Lublin 20-093, Poland
2Department of Biological Bases of Animal Production, University of Life Sciences in Lublin, Lublin 20-950, Poland

Correspondence should be addressed to Magdalena Izdebska; lp.bulmu@aksbedzi.aneladgam

Received 20 August 2018; Revised 20 October 2018; Accepted 28 October 2018; Published 8 November 2018

Academic Editor: Milton O. Moraes

Copyright © 2018 Mariola Herbet et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Doolin, C. Farrell, L. Tozzi, A. Harkin, T. Frodl, and V. O’Keane, “Diurnal hypothalamic-pituitary-adrenal axis measures and inflammatory marker correlates in major depressive disorder,” International Journal of Molecular Sciences, vol. 18, no. 10, 2017. View at Google Scholar · View at Scopus
  2. G. Guidotti, F. Calabrese, C. Anacker, G. Racagni, C. M. Pariante, and M. A. Riva, “Glucocorticoid receptor and fkbp5 expression is altered following exposure to chronic stress: modulation by antidepressant treatment,” Neuropsychopharmacology, vol. 38, no. 4, pp. 616–627, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. World Health Organization, “Depression and Other Common Mental Disorders,” in Global Health Estimates; WHO reference number: WHO/MSD/MER/2017.2, 2017, http://www.who.int/mental_health/management/depression/prevalence_global_health_estimates/en/.WHO reference number: WHO/MSD/MER/2017.2. View at Google Scholar
  4. N. Bakunina, C. M. Pariante, and P. A. Zunszain, “Immune mechanisms linked to depression via oxidative stress and neuroprogression,” The Journal of Immunology, vol. 144, no. 3, pp. 365–373, 2015. View at Publisher · View at Google Scholar
  5. B. E. Leonard, “The concept of depression as a dysfunction of the immune system,” Current Immunology Reviews, vol. 6, no. 3, pp. 205–212, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Sowa-Kućma, K. Styczeń, M. Siwek et al., “Lipid peroxidation and immune biomarkers are associated with major depression and its phenotypes, including treatment-resistant depression and melancholia,” Neurotoxicity Research, pp. 1–13, 2017. View at Google Scholar · View at Scopus
  7. E. Birben, U. M. Sahiner, C. Sackesen, S. Erzurum, and O. Kalayci, “Oxidative stress and antioxidant defense,” World Allergy Organization Journal, vol. 5, no. 1, pp. 9–19, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. T. M. Michel, D. Pülschen, and J. Thome, “The role of oxidative stress in depressive disorders,” Current Pharmaceutical Design, vol. 18, no. 32, pp. 5890–5899, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Vaváková, Z. Ďuračková, and J. Trebatická, “Markers of oxidative stress and neuroprogression in depression disorder,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 898393, 12 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Dowlati, N. Herrmann, W. Swardfager et al., “A meta-analysis of cytokines in major depression,” Biological Psychiatry, vol. 67, no. 5, pp. 446–457, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. C. L. Raison, L. Capuron, and A. H. Miller, “Cytokines sing the blues: inflammation and the pathogenesis of depression,” Trends in Immunology, vol. 27, no. 1, pp. 24–31, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. J. M. Gostner, K. Becker, D. Fuchs, and R. Sucher, “Redox regulation of the immune response,” Redox Report, vol. 18, no. 3, pp. 88–94, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. M. G. Traber, “Vitamin E regulatory mechanisms,” Annual Review of Nutrition, vol. 27, no. 1, pp. 347–362, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. Q. Jiang, “Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy,” Free Radical Biology & Medicine, vol. 72, pp. 76–90, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. G. D. Gamaro, L. P. Manoli, I. L. S. Torres, R. Silveira, and C. Dalmaz, “Effects of chronic variate stress on feeding behavior and on monoamine levels in different rat brain structures,” Neurochemistry International, vol. 42, no. 2, pp. 107–114, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Tagliari, C. G. Noschang, A. G. K. Ferreira et al., “Chronic variable stress impairs energy metabolism in prefrontal cortex and hippocampus of rats: Prevention by chronic antioxidant treatment,” Metabolic Brain Disease, vol. 25, no. 2, pp. 169–176, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Tagliari, A. P. Tagliari, F. Schmitz, A. A. Da Cunha, C. Dalmaz, and A. T. S. Wyse, “Chronic variable stress alters inflammatory and cholinergic parameters in hippocampus of rats,” Neurochemical Research, vol. 36, no. 3, pp. 487–493, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Trilla, “Involvement of the FKBP5 gene in the pathogenesis of stress-related disorders and antidepressant response: An update,” Maastricht Student Journal of Psychology and Neuroscience, vol. 3, pp. 117–133, 2014, http://openjournals.maastrichtuniversity.nl/MSJPN/article/view/60. View at Google Scholar
  19. J. C. O'Leary III, B. Zhang, J. Koren III, L. Blair, and C. A. Dickey, “The role of FKBP5 in mood disorders: Action of FKBP5 on steroid hormone receptors leads to questions about its evolutionary importance,” CNS and Neurological Disorders - Drug Targets, vol. 12, no. 8, pp. 1157–1162, 2013. View at Google Scholar · View at Scopus
  20. A. Menke, T. Klengel, J. Rubel et al., “Genetic variation in FKBP5 associated with the extent of stress hormone dysregulation in major depression,” Genes, Brain and Behavior, vol. 12, no. 3, pp. 289–296, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Lavebratt, E. Åberg, L. K. Sjöholm, and Y. Forsell, “Variations in FKBP5 and BDNF genes are suggestively associated with depression in a Swedish population-based cohort,” Journal of Affective Disorders, vol. 125, no. 1-3, pp. 249–255, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Zimmermann, T. Brückl, A. Nocon et al., “Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: Results from a 10 -year prospective community study,” The American Journal of Psychiatry, vol. 168, no. 10, pp. 1107–1116, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Bach-Mizrachi, M. D. Underwood, S. A. Kassir et al., “Neuronal tryptophan hydroxylase mRNA expression in the human dorsal and median raphe nuclei: Major depression and suicide,” Neuropsychopharmacology, vol. 31, no. 4, pp. 814–824, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Herbet, A. Korga, M. Gawrońska-Grzywacz et al., “Chronic Variable Stress is Responsible for Lipid and DNA Oxidative Disorders and Activation of Oxidative Stress Response Genes in the Brain of Rats,” Oxidative Medicine and Cellular Longevity, vol. 2017, 2017. View at Google Scholar · View at Scopus
  25. S. Scharf, C. Liebl, E. Binder, M. Schmidt, and M. Müller, “Expression and regulation of the Fkbp5 gene in the adult mouse brain,” Pharmacopsychiatry, vol. 44, no. 06, 2011. View at Publisher · View at Google Scholar
  26. X. Zhang, R. R. Gainetdinov, J.-M. Beaulieu et al., “Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression,” Neuron, vol. 45, no. 1, pp. 11–16, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Du, Z. Zhang, W. Li, L. He, J. Xu, and Y. Shi, “Association study of the TPH2 Gene with Major Depressive Disorder in the Han Chinese Population,” The European Journal of Psychiatry, vol. 30, 2016. View at Google Scholar
  28. K.-P. Lesch, N. Araragi, J. Waider, D. van den Hove, and L. Gutknecht, “Targeting brain serotonin synthesis: Insights into neurodevelopmental disorders with long-term outcomes related to negative emotionality, aggression and antisocial behaviour,” Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 367, no. 1601, pp. 2426–2443, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. G.-L. Chen and G. M. Miller, “Advances in tryptophan hydroxylase-2 gene expression regulation: New insights into serotonin-stress interaction and clinical implications,” American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, vol. 159, no. 2, pp. 152–171, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. B. S. Diniz, A. P. Mendes-Silva, L. B. Silva et al., “Oxidative stress markers imbalance in late-life depression,” Journal of Psychiatric Research, vol. 102, pp. 29–33, 2018. View at Publisher · View at Google Scholar · View at Scopus
  31. G. M. Enns and T. M. Cowan, “Glutathione as a redox biomarker in mitochondrial disease-implications for therapy,” Journal of Clinical Medicine, vol. 6, no. 50, 2017. View at Publisher · View at Google Scholar
  32. J. B. Schulz, J. Lindenau, J. Seyfried, and J. Dichgans, “Glutathione, oxidative stress and neurodegeneration,” European Journal of Biochemistry, vol. 267, no. 16, pp. 4904–4911, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. D. P. Jones, “Redox potential of GSH/GSSG couple: assay and biological significance,” Methods in Enzymology, vol. 348, pp. 93–112, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Yip, X. Geng, J. Shen, and Y. Ding, “Cerebral Gluconeogenesis and Diseases,” Frontiers in Pharmacology, vol. 7, 2017. View at Publisher · View at Google Scholar
  35. M. Herbet, M. Izdebska, I. Piątkowska-Chmiel, E. Poleszak, and E. Jagiełło-Wójtowicz, “Estimation of oxidative stress parameters in rats after simultaneous administration of rosuvastatin with antidepressants,” Pharmacological Reports, vol. 68, no. 1, pp. 172–176, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Li, R. W. Browne, M. R. Bonner, F. Deng, L. Tian, and L. Mu, “Positive Relationship between Total Antioxidant Status and Chemokines Observed in Adults,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 693680, 6 pages, 2014. View at Publisher · View at Google Scholar
  37. E. L. Mackenzie, K. Iwasaki, and Y. Tsuji, “Intracellular iron transport and storage: from molecular mechanisms to health implications,” Antioxidants & Redox Signaling, vol. 10, no. 6, pp. 997–1030, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. C. N. Black, M. Bot, P. G. Scheffer, H. Snieder, and B. W. J. H. Penninx, “Uric acid in major depressive and anxiety disorders,” Journal of Affective Disorders, vol. 225, pp. 684–690, 2018. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Bob, J. Raboch, M. Maes et al., “Depression, traumatic stress and interleukin-6,” Journal of Affective Disorders, vol. 120, no. 1-3, pp. 231–234, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. B. Hsu, D. Wang, Y. Sun et al., “SAT0182Improvement in Measures of Depressed Mood and Anhedonia, and Fatigue, In a Randomized, Placebo-Controlled, Phase 2 Study of Sirukumab, A Human Anti-Interleukin-6 Antibody, In Patients with Rheumatoid Arthritis,” Annals of the Rheumatic Diseases, vol. 74, no. Suppl 2, pp. 720.3–721, 2015. View at Publisher · View at Google Scholar
  41. G. E. Hodes, C. Ménard, and S. J. Russo, “Integrating Interleukin-6 into depression diagnosis and treatment,” Neurobiology of Stress, vol. 4, pp. 15–22, 2016. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Fischer and O. Maier, “Interrelation of Oxidative Stress and Inflammation in Neurodegenerative Disease: Role of TNF,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 610813, 18 pages, 2015. View at Publisher · View at Google Scholar
  43. I. Goshen and R. Yirmiya, “Interleukin-1 (IL-1): A central regulator of stress responses,” Frontiers in Neuroendocrinology, vol. 30, no. 1, pp. 30–45, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. J. L. Voorhees, A. J. Tarr, E. S. Wohleb et al., “Prolonged Restraint Stress Increases IL-6, Reduces IL-10, and Causes Persistent Depressive-Like Behavior That Is Reversed by Recombinant IL-10,” PLoS ONE, vol. 8, no. 3, Article ID e58488, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. S. J. Motivala, A. Sarfatti, L. Olmos, and M. R. Irwin, “Inflammatory markers and sleep disturbance in major depression,” Psychosomatic Medicine, vol. 67, no. 2, pp. 187–194, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Lu, C. S. Ho, X. Liu et al., “Chronic administration of fluoxetine and pro-inflammatory cytokine change in a rat model of depression,” PLoS ONE, vol. 12, no. 10, p. e0186700, 2017. View at Publisher · View at Google Scholar
  47. H. Ahsan, A. Ahad, J. Iqbal, and W. A. Siddiqui, “Pharmacological potential of tocotrienols: a review,” Nutrition & Metabolism, vol. 11, article 52, 2014. View at Publisher · View at Google Scholar
  48. C. M. Pariante, “The glucocorticoid receptor: Part of the solution or part of the problem?” Journal of Psychopharmacology, vol. 20, no. 4, pp. 79–84, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. W. Chen, T. Dang, R. D. Blind et al., “Glucocorticoid receptor phosphorylation differentially affects target gene expression,” Molecular Endocrinology, vol. 22, no. 8, pp. 1754–1766, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. L. M. Manosso, V. B. Neis, M. Moretti et al., “Antidepressant-like effect of α-tocopherol in a mouse model of depressive-like behavior induced by TNF-α,” Progress in Neuro-Psychopharmacology & Biological Psychiatry, vol. 46, pp. 48–57, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. H. Chalouati, M. M. Ben Sâad, and L. Payrastre, “Hepatoprotective effects of vitamin E against hexachlorobenzene-induced hepatotoxicity and oxidative stress in rats: histological, biochimical and antioxidant status changes,” Toxicology Mechanisms and Methods, pp. 1–8, 2018. View at Publisher · View at Google Scholar
  52. N. Stojiljkovic, S. Ilic, M. Veljkovic, J. Todorovic, and M. Mladenovic, “α-Tocopherol Reduces Morphological Changes and Oxidative Stress during Gentamicin-Induced Acute Renal Failure,” Bulletin of Experimental Biology and Medicine, vol. 164, no. 4, pp. 442–445, 2018. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Yilmaz, E. Kaya, and S. Comakli, “Vitamin E (α tocopherol) attenuates toxicity and oxidative stress induced by aflatoxin in rats,” Advances in Clinical and Experimental Medicine, vol. 26, no. 6, pp. 907–917, 2017. View at Publisher · View at Google Scholar · View at Scopus
  54. B. Amir Aslani and S. Ghobadi, “Studies on oxidants and antioxidants with a brief glance at their relevance to the immune system,” Life Sciences, vol. 146, pp. 163–173, 2016. View at Publisher · View at Google Scholar